These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
102 related items for PubMed ID: 776466
21. Local production of inflammatory mediators in an experimental model of acute obstructive pyelonephritis. Kaboré AF, Simard M, Bergeron MG. J Infect Dis; 1999 May; 179(5):1162-72. PubMed ID: 10191219 [Abstract] [Full Text] [Related]
22. [Antibody response to P-fimbriae of Escherichia coli in patients with genitourinary infections]. Kanai S, Miyake K, Agata N, Ohta M, Kato N. Hinyokika Kiyo; 1990 Jan; 36(1):1-6. PubMed ID: 1968696 [Abstract] [Full Text] [Related]
23. [Effect of cyclophosphamide in experimental pyelonephritis in mice]. Slavcheva E, Ivanova E, Georgiev D. Eksp Med Morfol; 1984 Jan; 23(4):186-95. PubMed ID: 6396063 [No Abstract] [Full Text] [Related]
24. [Local autovaccine treatment of experimental urinary tract infections in the rat]. Straube E, Broschewitz U. Z Urol Nephrol; 1988 Jan; 81(1):1-12. PubMed ID: 3284238 [Abstract] [Full Text] [Related]
25. The local immune response to Escherichia coli O and K antigen in experimental pyelonephritis. Smith JW, Kaijser B. J Clin Invest; 1976 Aug; 58(2):276-81. PubMed ID: 783196 [Abstract] [Full Text] [Related]
26. Experimental Escherichia coli 06 infection in mice. II. Protective factors of immunity after immunosuppression. Ahlstedt S. Scand J Infect Dis Suppl; 1980 Aug; Suppl 24():216-9. PubMed ID: 7010558 [Abstract] [Full Text] [Related]
31. The influence of cyclophosphamide and 6-mercaptopurine on the IgG1 and IgG2 immune response in guinea-pigs. Drössler K, Klima F, Ambrosius H. Immunology; 1981 Sep; 44(1):61-6. PubMed ID: 6168570 [Abstract] [Full Text] [Related]
32. Experimental Escherichia coli O6 pyelonephritis in rabbits. Effect on O6 antibody quantity and avidity of prior immunization with E. coli O2 bacteria. Ahlstedt S, Kaijser B. Immunology; 1975 May; 28(5):841-6. PubMed ID: 1093966 [Abstract] [Full Text] [Related]
35. Melatonin prevents neutrophil-mediated oxidative injury in Escherichia coli-induced pyelonephritis in rats. Sener G, Tuğtepe H, Velioğlu-Oğünç A, Cetinel S, Gedik N, Yeğen BC. J Pineal Res; 2006 Oct; 41(3):220-7. PubMed ID: 16948782 [Abstract] [Full Text] [Related]
36. Immunobacteriological aspects of pyelonephritis. Miller TE, Stewart E, North JD. Contrib Nephrol; 1979 Oct; 16():11-5. PubMed ID: 380894 [No Abstract] [Full Text] [Related]
37. The effects of cobra venom factor, an inhibitor of the complement system, on the sequence of morphological events in the rat kidney in experimental pyelonephritis. Sullivan MJ, Harvey RA, Shimamura T. Yale J Biol Med; 1977 Oct; 50(3):267-73. PubMed ID: 329591 [Abstract] [Full Text] [Related]
38. Immunofluorescent localization of bacterial antigen in pyelonephritis. I. The use of antisera against the common enterobacterial antigen in experimental renal lesions. Aoki S, Merkel M, Aoki M, McCabe WR. J Lab Clin Med; 1967 Aug; 70(2):204-12. PubMed ID: 5339482 [No Abstract] [Full Text] [Related]
39. Prevention of chronic experimental pyelonephritis by suppression of acute suppuration. Glauser MP, Lyons JM, Braude AI. J Clin Invest; 1978 Feb; 61(2):403-7. PubMed ID: 621280 [Abstract] [Full Text] [Related]
40. Immunomodulatory interactions of suppressor cells, cell-mediated immunity, and cyclophosphamide in experimental pyelonephritis. Miller T. J Infect Dis; 1983 Dec; 148(6):1096-100. PubMed ID: 6228613 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]